View as cardsView as table112 Projects

Development of a novel therapeutic to accelerate epithelial repair following viral respiratory infection

Fiscal Year Awarded:

2027

Principal Investigator:

Ruth Franklin

Discovery and optimization of thyroid hormone modulating molecules

Fiscal Year Awarded:

2027

Principal Investigator:

Bernardo Sabatini

Induction of autoantigen-specific tolerance to reverse type 1 diabetes

Fiscal Year Awarded:

2027

Principal Investigator:

Amy Wagers

Melanocortin 1 receptor agonist for treating xeroderma pigmentosum and others at high-risk of skin cancers

Fiscal Year Awarded:

2027

Principal Investigator:

Andrew Kruse

Monoclonal antibodies for precision delivery of analgesic therapeutics to peripheral nervous system neurons

Fiscal Year Awarded:

2027

Principal Investigator:

David Ginty

Novel therapies for hair loss

Fiscal Year Awarded:

2027

Principal Investigator:

Ya-Chieh Hsu

Quantitative field-deployable diagnostic

Fiscal Year Awarded:

2027

Principal Investigator:

Michael Springer

Therapeutic strategies for scarless skin regeneration after injury

Fiscal Year Awarded:

2027

Principal Investigator:

Ya-Chieh Hsu

Tuning p53-dependent cell fate for radioprotection/mitigation

Fiscal Year Awarded:

2027

Principal Investigator:

Galit Lahav

Validating novel therapeutic targets in pulmonary arterial hypertension

Fiscal Year Awarded:

2027

Principal Investigator:

Adrian Salic

A degrader approach to mechanism-based therapeutics in pulmonary arterial hypertension

Fiscal Year Awarded:

2026

Principal Investigator:

Adrian Salic

A new approach to decode gene-based mechanisms and advance therapeutic options for cardiovascular disease and other aging-related disorders

Fiscal Year Awarded:

2026

Principal Investigator:

Amy Wagers

Advancing the development of HUWE1 inhibitors for cancer treatment

Fiscal Year Awarded:

2026

Principal Investigator:

Ying Lu

Bacterial siderophores for accelerated mineral weathering and carbon sequestration in seawater

Fiscal Year Awarded:

2026

Principal Investigator:

Pamela Silver

Brain specific modulation of thyroid hormone levels

Fiscal Year Awarded:

2026

Principal Investigator:

Bernardo Sabatini

Development of a novel therapeutic to accelerate epithelial repair following viral respiratory infection

Fiscal Year Awarded:

2026

Principal Investigator:

Ruth Franklin

Development of targeted ectodomain shedding molecules

Fiscal Year Awarded:

2026

Principal Investigator:

Stephen Blacklow

Enhanced dual-AAV gene delivery to treat hereditary deafness

Fiscal Year Awarded:

2026

Principal Investigator:

David Corey

Enhancing regulatory T cell function for adoptive CAR Treg therapy to treat autoimmune disease

Fiscal Year Awarded:

2026

Principal Investigator:

Arlene Sharpe

Melanocortin 1 receptor agonists for preventing skin cancer

Fiscal Year Awarded:

2026

Principal Investigator:

Andrew Kruse